Bring Truth to Every Trial: TruTechnologies™ Debuts New Brand Identity as Pharma Industry Increasingly Rallies Behind Clinical Trial Modernization

TruTechnologies, a clinical trial software company delivering real-time visibility into trial execution at the point of care, today reveals a new brand identity and updated website. 

This reimagining of the brand comes as the pharmaceutical industry reaches a critical inflection point. Recent federal initiatives, including the FDA’s real-time clinical trials pilot program and HHS’s Operation TrialBlazer, have put renewed focus on modernizing clinical development to reduce the dead time that slows trials and strengthen U.S. leadership in drug innovation. 

As the FDA’s real-time pilot announcement noted, clinical trials have been conducted in much the same way for 60 years, with key data signals often taking years to reach regulators. Yet despite years of technology investment across clinical development, that timeline hasn’t meaningfully improved because sponsors still face persistent blind spots in how critical trial activities are executed at the site level. Closing those gaps is essential to reducing avoidable delays, improving trust in trial data, and enabling teams to make faster development decisions. 

TruTechnologies was built for this moment. Since its founding in 2018, the company has focused on helping sponsors and sites identify issues earlier, act sooner, and move trials forward with greater confidence. The company’s platform is designed to support:  

• Truly real-time trial execution: Live data is made available the moment it’s captured at the point of care, not when it’s entered into an electronic system days or weeks later — a much-needed departure from the industry’s standard “real-time” offerings.
• Protocol-guided workflows: Validated, mobile-first workflows prevent out-of-protocol actions before they happen, supporting data quality from the start.
• Sponsor live-streams: Sponsors have real-time visibility into what’s happening at the site level, allowing them to detect and resolve issues as they occur.

“Our refreshed brand identity isn’t just a new logo and website; it’s part of our broader commitment to shepherd the industry into a new era of live, truly real-time clinical trial oversight,” said Scott Ogle, CEO and co-founder of TruTechnologies. “Our new look and feel is rooted in the exact simplicity we are bringing to sites and sponsors each day and is aligned with the sense of urgency  we are seeing from the industry at large for faster, clearer, and more confident clinical trial execution.” 

The rebrand comes as TruTechnologies experiences rapid growth, including a recent strategic investment from LLR Partners and increasing adoption of its TruLab® platform, now deployed across more than 3,300 clinical sites in 60 countries. The company has secured partnerships with top pharmaceutical and biotech companies, helping accelerate protocol adherence, reduce risk, and improve data quality. TruLab has demonstrated up to a 97% reduction in source data errors, a 98% reduction in sample-related queries, an 85% reduction in sponsor time spent on sample tracking, and the potential to reduce time to market by up to three months.

“I often liken clinical trial modernization to a 60-year-old home, badly in need of updating. At TruTechnologies, we don’t believe in patchwork renovations, but instead feel strongly that we need to fix clinical trial execution from the foundation,” said Dr. Richard Graham, Chairman of the Board and co-founder of TruTechnologies. “Our new brand identity reflects the spirit of our team and technology, which represents a fearlessness to break free from legacy clinical trial inefficiencies.”